subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB

object_name: malignant soft tissue neoplasm

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: sarcoma


subject: UMLS:C2744646

object_name: non-small cell lung carcinoma


subject: UMLS:C2744646

object_name: Disseminated Malignant Neoplasm

tested_intervention: yes


subject: UMLS:C2744646

object_name: Embolism, Tumor


subject: UMLS:C2744646

object_name: Neoplasm Metastasis


subject: UMLS:C2744646

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C2744646

object_name: adult lymphoma


subject: UMLS:C2744646

object_name: lymphoma


subject: UMLS:C2744646

object_name: pediatric lymphoma


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: migraine


subject: CHEBI:27470

subject_name: Folic acid

object_name: Perinatal death


subject: CHEBI:27470

object_name: abortion


subject: CHEBI:27470

object_name: Fetal Death


subject: CHEBI:18248

subject_name: Iron


subject: CHEBI:18248


subject: CHEBI:18248


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: CHEBI:46662

subject_name: mineral


subject: CHEBI:46662


subject: CHEBI:46662


subject: UNII:69VKY8P7EA

object_name: PPoma


subject: UNII:69VKY8P7EA

object_name: recurrent islet cell carcinoma


subject: UNII:69VKY8P7EA

object_name: pancreatic neoplasm of uncertain behavior somatostatinoma


subject: UNII:69VKY8P7EA

object_name: pancreatic somatostatinoma


subject: UNII:69VKY8P7EA

object_name: somatostatinoma


subject: UNII:69VKY8P7EA

object_name: glucagonoma


subject: UNII:69VKY8P7EA

object_name: insulinoma


subject: UNII:69VKY8P7EA

object_name: Zollinger-Ellison syndrome


subject: UNII:69VKY8P7EA

object_name: gastrinoma


subject: UNII:69VKY8P7EA

object_name: pancreatic gastrinoma


subject: UMLS:C2700458

subject_name: Dovitinib Lactate


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: UMLS:C2700458


subject: PUBCHEM.COMPOUND:23144079

subject_name: Milataxel

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:23144079

object_name: rectal neoplasm


subject: PUBCHEM.COMPOUND:23144079

object_name: Colon Neoplasm


subject: UMLS:C3827051

subject_name: HyperAcute Renal

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C3827051

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C3827051

object_name: Renal cell carcinoma recurrent


subject: UMLS:C3827051

object_name: Refractory Renal Cell Carcinoma


subject: UMLS:C3827051

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C3815169

subject_name: Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine


subject: UMLS:C3815169


subject: UMLS:C3815169


subject: UMLS:C3815169


subject: UMLS:C3815169


subject: PR:000010012

subject_name: lymphatic vessel endothelial hyaluronic acid receptor 1


subject: PR:000010012


subject: PR:000010012


subject: PR:000010012


subject: PR:000010012


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]


subject: UMLS:C5848866


subject: UMLS:C5848866


subject: UMLS:C5848866


subject: UMLS:C5848866


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: endometrium adenocarcinoma


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C5556351

object_name: Gastroesophageal junction cancer


subject: CHEBI:355510

subject_name: Cefotiam

object_name: Gastric varix


subject: CHEBI:355510

object_name: Cirrhosis


subject: CHEBI:355510

object_name: liver cirrhosis


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: traumatic encephalopathy


subject: CHEBI:16581

object_name: traumatic brain injury


subject: CHEBI:71940

subject_name: Tadalafil

object_name: congenital heart disease


subject: CHEBI:71940

object_name: congenitally corrected transposition of the great arteries


subject: GTOPDB:3738

subject_name: PTHrP

object_name: hyperparathyroidism


subject: GTOPDB:3738

object_name: Hyperparathyroidism, CTCAE


subject: GTOPDB:3738

object_name: humoral hypercalcemia of malignancy


subject: PR:000013433

subject_name: parathyroid hormone-related protein


subject: PR:000013433


subject: PR:000013433


subject: UMLS:C3887570

subject_name: Recombinant Parathyroid Hormone-Related Protein


subject: UMLS:C3887570


subject: UMLS:C3887570


subject: UniProtKB:P22858

subject_name: PTHR_MOUSE Parathyroid hormone-related protein (sprot)


subject: UniProtKB:P22858


subject: UniProtKB:P22858


subject: GTOPDB:12990

subject_name: sintilimab

object_name: nasopharyngeal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: rectal carcinoma


subject: CHEBI:192614

object_name: rectal cancer


subject: CHEBI:192614

object_name: Childhood Rectal Carcinoma


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: UMLS:C3896934

subject_name: Allogeneic Cellular Vaccine 1650-G

object_name: non-small cell lung carcinoma


subject: CHEBI:17026

subject_name: Progesterone

object_name: Recurrent pregnancy loss without current pregnancy


subject: GTOPDB:1160

subject_name: hCG


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: CHEBI:84500

subject_name: varenicline

object_name: Adherence To Medication Regime


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: rheumatoid arthritis


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Pregnant


subject: CHEBI:135207

object_name: ectopic pregnancy


subject: CHEBI:135207

object_name: preeclampsia


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: UNII:12M6KFD07E

subject_name: Lanopepden

object_name: cellulitis


subject: UMLS:C2826229

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: CHEBI:17376

subject_name: cystine

object_name: Tobacco user


subject: CHEBI:17376

object_name: Tobacco use history


subject: CHEBI:17376

object_name: Encounter due to tobacco use


subject: CHEBI:17376

object_name: alcohol abuse


subject: CHEBI:17376

object_name: alcohol dependence


subject: CHEBI:17376

object_name: HIV infection


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16494

subject_name: thioctic acid

object_name: post-operative atrial fibrillation


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: acute myocardial infarction


subject: UNII:PP0SHH6V16

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Atypical Burkitt's lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864

object_name: Adult Burkitt Lymphoma


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174

object_name: Burkitt lymphoma


subject: CHEBI:191174

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: liver neoplasm


subject: UNII:52CMI0WC3Y

object_name: Adult Liver Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:94463

object_name: liver cancer


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: CHEBI:85083


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: PUBCHEM.COMPOUND:77335690


subject: PUBCHEM.COMPOUND:77335690


subject: PUBCHEM.COMPOUND:122197547

subject_name: VOXILAPREVIR


subject: PUBCHEM.COMPOUND:122197547


subject: PUBCHEM.COMPOUND:122197547


subject: PUBCHEM.COMPOUND:122197547

object_name: liver carcinoma


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Refractory Central Nervous System Lymphoma


subject: CHEBI:91397

object_name: Recurrent Central Nervous System Lymphoma


subject: CHEBI:91397

object_name: Central Nervous System B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone

object_name: heart failure


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Fusion of spine (disease)


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:91414

subject_name: Adavosertib

object_name: plasma cell myeloma


subject: CHEBI:91414

object_name: adult lymphoma


subject: CHEBI:91414

object_name: lymphoma


subject: CHEBI:91414

object_name: pediatric lymphoma


subject: CHEBI:91414

object_name: Plasma cell myeloma refractory


subject: CHEBI:91414

object_name: Refractory Lymphoma


subject: CHEBI:91414

object_name: Advanced Lymphoma


subject: CHEBI:91414

object_name: Plasma cell myeloma recurrent


subject: CHEBI:91414

object_name: Recurrent Lymphoma


subject: CHEBI:91414

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:91414

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:91414

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:91414

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:91414

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:91414

object_name: Recurrent Rectal Cancer


subject: CHEBI:91414

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:91414

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:91414

object_name: Neck Carcinoma


subject: CHEBI:91414

object_name: uterine corpus cancer


subject: CHEBI:91414

object_name: Prostate cancer recurrent


subject: CHEBI:91414

object_name: endometrial carcinoma


subject: CHEBI:91414

object_name: Breast cancer recurrent


subject: CHEBI:91414

object_name: Colorectal cancer recurrent


subject: CHEBI:91414

object_name: Recurrent ovarian cancer


subject: CHEBI:91414

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:91414

object_name: Cervix carcinoma recurrent


subject: CHEBI:91414

object_name: recurrent gastric cancer


subject: CHEBI:91414

object_name: Bladder cancer recurrent


subject: CHEBI:91414

object_name: Recurrent Liver Carcinoma


subject: CHEBI:91414

object_name: Colon cancer recurrent


subject: CHEBI:91414

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:91414

object_name: Recurrent Skin Carcinoma


subject: CHEBI:91414

object_name: thyroid gland carcinoma


subject: CHEBI:91414

object_name: breast carcinoma


subject: CHEBI:91414

object_name: colorectal carcinoma


subject: CHEBI:91414

object_name: Melanoma recurrent


subject: CHEBI:91414

object_name: carcinoma of esophagus


subject: CHEBI:91414

object_name: rectal carcinoma


subject: CHEBI:91414

object_name: rectum adenocarcinoma


subject: CHEBI:91414

object_name: Recurrent Glioma


subject: CHEBI:91414

object_name: suppressor of tumorigenicity 3


subject: CHEBI:91414

object_name: cervical carcinoma


subject: CHEBI:91414

object_name: Stomach cancer


subject: CHEBI:91414

object_name: malignant epithelial tumor of ovary


subject: CHEBI:91414

object_name: urinary bladder carcinoma


subject: CHEBI:91414

object_name: renal carcinoma


subject: CHEBI:91414

object_name: renal cell carcinoma


subject: CHEBI:91414

object_name: liver carcinoma


subject: CHEBI:91414

object_name: colon carcinoma


subject: CHEBI:91414

object_name: lung carcinoma


subject: CHEBI:91414

object_name: skin carcinoma


subject: CHEBI:91414

object_name: melanoma


subject: CHEBI:91414

object_name: glioma


subject: CHEBI:91414

object_name: malignant glioma


subject: CHEBI:91400

subject_name: Afatinib

object_name: plasma cell myeloma


subject: CHEBI:91400

object_name: adult lymphoma


subject: CHEBI:91400

object_name: lymphoma


subject: CHEBI:91400

object_name: pediatric lymphoma


subject: CHEBI:91400

object_name: Plasma cell myeloma refractory


subject: CHEBI:91400

object_name: Refractory Lymphoma


subject: CHEBI:91400

object_name: Advanced Lymphoma


subject: CHEBI:91400

object_name: Plasma cell myeloma recurrent


subject: CHEBI:91400

object_name: Recurrent Lymphoma


subject: CHEBI:91400

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:91400

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:91400

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:91400

object_name: Recurrent Rectal Cancer


subject: CHEBI:91400

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:91400

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:91400

object_name: Neck Carcinoma


subject: CHEBI:91400

object_name: uterine corpus cancer


subject: CHEBI:91400

object_name: Prostate cancer recurrent


subject: CHEBI:91400

object_name: endometrial carcinoma


subject: CHEBI:91400

object_name: uterine cancer


subject: CHEBI:91400

object_name: Breast cancer recurrent


subject: CHEBI:91400

object_name: Colorectal cancer recurrent


subject: CHEBI:91400

object_name: Recurrent ovarian cancer


subject: CHEBI:91400

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:91400

object_name: Cervix carcinoma recurrent


subject: CHEBI:91400

object_name: exocrine pancreatic carcinoma


subject: CHEBI:91400

object_name: recurrent gastric cancer


subject: CHEBI:91400

object_name: Bladder cancer recurrent


subject: CHEBI:91400

object_name: Recurrent Liver Carcinoma


subject: CHEBI:91400

object_name: Colon cancer recurrent


subject: CHEBI:91400

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:91400

object_name: Recurrent Skin Carcinoma


subject: CHEBI:91400

object_name: thyroid gland carcinoma


subject: CHEBI:91400

object_name: breast carcinoma


subject: CHEBI:91400

object_name: colorectal carcinoma


subject: CHEBI:91400

object_name: Melanoma recurrent


subject: CHEBI:91400

object_name: rectal carcinoma


subject: CHEBI:91400

object_name: rectum adenocarcinoma


subject: CHEBI:91400

object_name: Recurrent Glioma


subject: CHEBI:91400

object_name: suppressor of tumorigenicity 3


subject: CHEBI:91400

object_name: cervical carcinoma


subject: CHEBI:91400

object_name: prostate carcinoma


subject: CHEBI:91400

object_name: ovarian cancer


subject: CHEBI:91400

object_name: ovarian carcinoma


subject: CHEBI:91400

object_name: malignant epithelial tumor of ovary


subject: CHEBI:91400

object_name: urinary bladder carcinoma


subject: CHEBI:91400

object_name: renal carcinoma


subject: CHEBI:91400

object_name: renal cell carcinoma


subject: CHEBI:91400

object_name: liver carcinoma


subject: CHEBI:91400

object_name: colon carcinoma


subject: CHEBI:91400

object_name: skin carcinoma


subject: CHEBI:91400

object_name: melanoma


subject: CHEBI:91400

object_name: glioma


subject: CHEBI:91400

object_name: malignant glioma


subject: CHEBI:76003

subject_name: afatinib dimaleate

object_name: plasma cell myeloma


subject: CHEBI:76003

object_name: adult lymphoma


subject: CHEBI:76003

object_name: lymphoma


subject: CHEBI:76003

object_name: pediatric lymphoma


subject: CHEBI:76003

object_name: Plasma cell myeloma refractory


subject: CHEBI:76003

object_name: Refractory Lymphoma


subject: CHEBI:76003

object_name: Advanced Lymphoma


subject: CHEBI:76003

object_name: Plasma cell myeloma recurrent


subject: CHEBI:76003

object_name: Recurrent Lymphoma


subject: CHEBI:76003

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:76003

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:76003

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:76003

object_name: Recurrent Rectal Cancer


subject: CHEBI:76003

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:76003

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:76003

object_name: Neck Carcinoma


subject: CHEBI:76003

object_name: uterine corpus cancer


subject: CHEBI:76003

object_name: Prostate cancer recurrent


subject: CHEBI:76003

object_name: endometrial carcinoma


subject: CHEBI:76003

object_name: uterine cancer


subject: CHEBI:76003

object_name: Breast cancer recurrent


subject: CHEBI:76003

object_name: Colorectal cancer recurrent


subject: CHEBI:76003

object_name: Recurrent ovarian cancer


subject: CHEBI:76003

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:76003

object_name: Cervix carcinoma recurrent


subject: CHEBI:76003

object_name: exocrine pancreatic carcinoma


subject: CHEBI:76003

object_name: recurrent gastric cancer


subject: CHEBI:76003

object_name: Bladder cancer recurrent


subject: CHEBI:76003

object_name: Recurrent Liver Carcinoma


subject: CHEBI:76003

object_name: Colon cancer recurrent


subject: CHEBI:76003

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:76003

object_name: Recurrent Skin Carcinoma


subject: CHEBI:76003

object_name: thyroid gland carcinoma


subject: CHEBI:76003

object_name: breast carcinoma


subject: CHEBI:76003

object_name: colorectal carcinoma


subject: CHEBI:76003

object_name: Melanoma recurrent


subject: CHEBI:76003

object_name: carcinoma of esophagus


subject: CHEBI:76003

object_name: rectal carcinoma


subject: CHEBI:76003

object_name: rectum adenocarcinoma


subject: CHEBI:76003

object_name: Recurrent Glioma


subject: CHEBI:76003

object_name: suppressor of tumorigenicity 3


subject: CHEBI:76003

object_name: cervical carcinoma


subject: CHEBI:76003

object_name: prostate carcinoma


subject: CHEBI:76003

object_name: Stomach cancer


subject: CHEBI:76003

object_name: ovarian cancer


subject: CHEBI:76003

object_name: ovarian carcinoma


subject: CHEBI:76003

object_name: malignant epithelial tumor of ovary


subject: CHEBI:76003

object_name: urinary bladder carcinoma


subject: CHEBI:76003

object_name: renal carcinoma


subject: CHEBI:76003

object_name: renal cell carcinoma


subject: CHEBI:76003

object_name: liver carcinoma


subject: CHEBI:76003

object_name: colon carcinoma


subject: CHEBI:76003

object_name: lung carcinoma


subject: CHEBI:76003

object_name: skin carcinoma


subject: CHEBI:76003

object_name: melanoma


subject: CHEBI:76003

object_name: glioma


subject: CHEBI:76003

object_name: malignant glioma


subject: CHEBI:145371

subject_name: Binimetinib

object_name: plasma cell myeloma


subject: CHEBI:145371

object_name: adult lymphoma


subject: CHEBI:145371

object_name: lymphoma


subject: CHEBI:145371

object_name: pediatric lymphoma


subject: CHEBI:145371

object_name: Plasma cell myeloma refractory


subject: CHEBI:145371

object_name: Refractory Lymphoma


subject: CHEBI:145371

object_name: Advanced Lymphoma


subject: CHEBI:145371

object_name: Plasma cell myeloma recurrent


subject: CHEBI:145371

object_name: Recurrent Lymphoma


subject: CHEBI:145371

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:145371

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:145371

object_name: Recurrent Rectal Cancer


subject: CHEBI:145371

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:145371

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:145371

object_name: Neck Carcinoma


subject: CHEBI:145371

object_name: uterine corpus cancer


subject: CHEBI:145371

object_name: Prostate cancer recurrent


subject: CHEBI:145371

object_name: endometrial carcinoma


subject: CHEBI:145371

object_name: uterine cancer


subject: CHEBI:145371

object_name: Colorectal cancer recurrent


subject: CHEBI:145371

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:145371

object_name: Cervix carcinoma recurrent


subject: CHEBI:145371

object_name: recurrent gastric cancer


subject: CHEBI:145371

object_name: Bladder cancer recurrent


subject: CHEBI:145371

object_name: Recurrent Liver Carcinoma


subject: CHEBI:145371

object_name: Colon cancer recurrent


subject: CHEBI:145371

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:145371

object_name: Recurrent Skin Carcinoma


subject: CHEBI:145371

object_name: thyroid gland carcinoma


subject: CHEBI:145371

object_name: breast carcinoma


subject: CHEBI:145371

object_name: carcinoma of esophagus


subject: CHEBI:145371

object_name: rectal carcinoma


subject: CHEBI:145371

object_name: rectum adenocarcinoma


subject: CHEBI:145371

object_name: Recurrent Glioma


subject: CHEBI:145371

object_name: suppressor of tumorigenicity 3


subject: CHEBI:145371

object_name: cervical carcinoma


subject: CHEBI:145371

object_name: prostate carcinoma


subject: CHEBI:145371

object_name: Stomach cancer


subject: CHEBI:145371

object_name: ovarian cancer


subject: CHEBI:145371

object_name: ovarian carcinoma


subject: CHEBI:145371

object_name: malignant epithelial tumor of ovary


subject: CHEBI:145371

object_name: urinary bladder carcinoma


subject: CHEBI:145371

object_name: renal carcinoma


subject: CHEBI:145371

object_name: renal cell carcinoma


subject: CHEBI:145371

object_name: liver carcinoma


subject: CHEBI:145371

object_name: colon carcinoma


subject: CHEBI:145371

object_name: glioma


subject: CHEBI:145371

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:42602260

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:42602260

object_name: lymphoma


subject: PUBCHEM.COMPOUND:42602260

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Lymphoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Advanced Lymphoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Lymphoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:42602260

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:42602260

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:42602260

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Thyroid Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: Colorectal cancer recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Oesophageal carcinoma recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Cervix carcinoma recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: Bladder cancer recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Liver Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Unspecified Lung Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Skin Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:42602260

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Glioma


subject: PUBCHEM.COMPOUND:42602260

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:42602260

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:42602260

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: skin carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: melanoma


subject: PUBCHEM.COMPOUND:42602260

object_name: glioma


subject: PUBCHEM.COMPOUND:42602260

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:135565596

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Advanced Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Thyroid Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: uterine cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Colorectal cancer recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Oesophageal carcinoma recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Cervix carcinoma recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Bladder cancer recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Liver Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Unspecified Lung Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Skin Carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Melanoma recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:135565596

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: rectum adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Glioma


subject: PUBCHEM.COMPOUND:135565596

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:135565596

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: malignant epithelial tumor of ovary


subject: PUBCHEM.COMPOUND:135565596

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: skin carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: melanoma


subject: PUBCHEM.COMPOUND:135565596

object_name: glioma


subject: PUBCHEM.COMPOUND:135565596

object_name: malignant glioma


subject: CHEBI:173077

object_name: plasma cell myeloma


subject: CHEBI:173077

object_name: adult lymphoma


subject: CHEBI:173077

object_name: lymphoma


subject: CHEBI:173077

object_name: pediatric lymphoma


subject: CHEBI:173077

object_name: Plasma cell myeloma refractory


subject: CHEBI:173077

object_name: Refractory Lymphoma


subject: CHEBI:173077

object_name: Advanced Lymphoma


subject: CHEBI:173077

object_name: Plasma cell myeloma recurrent


subject: CHEBI:173077

object_name: Recurrent Lymphoma


subject: CHEBI:173077

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:173077

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:173077

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:173077

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:173077

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:173077

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:173077

object_name: Recurrent Rectal Cancer


subject: CHEBI:173077

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:173077

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:173077

object_name: Neck Carcinoma


subject: CHEBI:173077

object_name: Prostate cancer recurrent


subject: CHEBI:173077

object_name: uterine cancer


subject: CHEBI:173077

object_name: Breast cancer recurrent


subject: CHEBI:173077

object_name: Colorectal cancer recurrent


subject: CHEBI:173077

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:173077

object_name: Cervix carcinoma recurrent


subject: CHEBI:173077

object_name: exocrine pancreatic carcinoma


subject: CHEBI:173077

object_name: recurrent gastric cancer


subject: CHEBI:173077

object_name: Bladder cancer recurrent


subject: CHEBI:173077

object_name: Recurrent Liver Carcinoma


subject: CHEBI:173077

object_name: Colon cancer recurrent


subject: CHEBI:173077

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:173077

object_name: Recurrent Skin Carcinoma


subject: CHEBI:173077

object_name: thyroid gland carcinoma


subject: CHEBI:173077

object_name: breast carcinoma


subject: CHEBI:173077

object_name: colorectal carcinoma


subject: CHEBI:173077

object_name: Melanoma recurrent


subject: CHEBI:173077

object_name: carcinoma of esophagus


subject: CHEBI:173077

object_name: rectal carcinoma


subject: CHEBI:173077

object_name: rectum adenocarcinoma


subject: CHEBI:173077

object_name: Recurrent Glioma


subject: CHEBI:173077

object_name: suppressor of tumorigenicity 3


subject: CHEBI:173077

object_name: cervical carcinoma


subject: CHEBI:173077

object_name: Stomach cancer


subject: CHEBI:173077

object_name: ovarian cancer


subject: CHEBI:173077

object_name: ovarian carcinoma


subject: CHEBI:173077

object_name: malignant epithelial tumor of ovary


subject: CHEBI:173077

object_name: urinary bladder carcinoma


subject: CHEBI:173077

object_name: renal carcinoma


subject: CHEBI:173077

object_name: renal cell carcinoma


subject: CHEBI:173077

object_name: liver carcinoma


subject: CHEBI:173077

object_name: colon carcinoma


subject: CHEBI:173077

object_name: lung carcinoma


subject: CHEBI:173077

object_name: skin carcinoma


subject: CHEBI:173077

object_name: melanoma


subject: CHEBI:173077

object_name: glioma


subject: CHEBI:173077

object_name: malignant glioma


subject: CHEBI:173081

subject_name: copanlisib dihydrochloride

object_name: plasma cell myeloma


subject: CHEBI:173081

object_name: adult lymphoma


subject: CHEBI:173081

object_name: lymphoma


subject: CHEBI:173081

object_name: pediatric lymphoma


subject: CHEBI:173081

object_name: Plasma cell myeloma refractory


subject: CHEBI:173081

object_name: Refractory Lymphoma


subject: CHEBI:173081

object_name: Advanced Lymphoma


subject: CHEBI:173081

object_name: Plasma cell myeloma recurrent


subject: CHEBI:173081

object_name: Recurrent Lymphoma


subject: CHEBI:173081

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:173081

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:173081

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:173081

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:173081

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:173081

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:173081

object_name: Recurrent Rectal Cancer


subject: CHEBI:173081

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:173081

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:173081

object_name: Neck Carcinoma


subject: CHEBI:173081

object_name: uterine corpus cancer


subject: CHEBI:173081

object_name: Prostate cancer recurrent


subject: CHEBI:173081

object_name: endometrial carcinoma


subject: CHEBI:173081

object_name: uterine cancer


subject: CHEBI:173081

object_name: Breast cancer recurrent


subject: CHEBI:173081

object_name: Colorectal cancer recurrent


subject: CHEBI:173081

object_name: Recurrent ovarian cancer


subject: CHEBI:173081

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:173081

object_name: Cervix carcinoma recurrent


subject: CHEBI:173081

object_name: exocrine pancreatic carcinoma


subject: CHEBI:173081

object_name: recurrent gastric cancer


subject: CHEBI:173081

object_name: Bladder cancer recurrent


subject: CHEBI:173081

object_name: Recurrent Liver Carcinoma


subject: CHEBI:173081

object_name: Colon cancer recurrent


subject: CHEBI:173081

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:173081

object_name: Recurrent Skin Carcinoma


subject: CHEBI:173081

object_name: thyroid gland carcinoma


subject: CHEBI:173081

object_name: breast carcinoma


subject: CHEBI:173081

object_name: colorectal carcinoma


subject: CHEBI:173081

object_name: Melanoma recurrent


subject: CHEBI:173081

object_name: carcinoma of esophagus


subject: CHEBI:173081

object_name: rectal carcinoma


subject: CHEBI:173081

object_name: rectum adenocarcinoma


subject: CHEBI:173081

object_name: Recurrent Glioma


subject: CHEBI:173081

object_name: suppressor of tumorigenicity 3


subject: CHEBI:173081

object_name: cervical carcinoma


subject: CHEBI:173081

object_name: prostate carcinoma


subject: CHEBI:173081

object_name: Stomach cancer


subject: CHEBI:173081

object_name: ovarian cancer


subject: CHEBI:173081

object_name: ovarian carcinoma


subject: CHEBI:173081

object_name: malignant epithelial tumor of ovary


subject: CHEBI:173081

object_name: urinary bladder carcinoma


subject: CHEBI:173081

object_name: renal carcinoma


subject: CHEBI:173081

object_name: renal cell carcinoma


subject: CHEBI:173081

object_name: liver carcinoma


subject: CHEBI:173081

object_name: colon carcinoma


subject: CHEBI:173081

object_name: lung carcinoma


subject: CHEBI:173081

object_name: skin carcinoma


subject: CHEBI:173081

object_name: melanoma


subject: CHEBI:173081

object_name: glioma


subject: CHEBI:173081

object_name: malignant glioma


subject: UMLS:C4528197

subject_name: Copanlisib dihydrochloride

object_name: plasma cell myeloma


subject: UMLS:C4528197

object_name: adult lymphoma


subject: UMLS:C4528197

object_name: lymphoma


subject: UMLS:C4528197

object_name: pediatric lymphoma


subject: UMLS:C4528197

object_name: Plasma cell myeloma refractory


subject: UMLS:C4528197

object_name: Refractory Lymphoma


subject: UMLS:C4528197

object_name: Advanced Lymphoma


subject: UMLS:C4528197

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4528197

object_name: Recurrent Lymphoma


subject: UMLS:C4528197

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C4528197

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4528197

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C4528197

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C4528197

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C4528197

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C4528197

object_name: Recurrent Rectal Cancer


subject: UMLS:C4528197

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C4528197

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C4528197

object_name: Neck Carcinoma


subject: UMLS:C4528197

object_name: uterine corpus cancer


subject: UMLS:C4528197

object_name: Prostate cancer recurrent


subject: UMLS:C4528197

object_name: endometrial carcinoma


subject: UMLS:C4528197

object_name: uterine cancer


subject: UMLS:C4528197

object_name: Breast cancer recurrent


subject: UMLS:C4528197

object_name: Colorectal cancer recurrent


subject: UMLS:C4528197

object_name: Recurrent ovarian cancer


subject: UMLS:C4528197

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C4528197

object_name: Cervix carcinoma recurrent


subject: UMLS:C4528197

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4528197

object_name: recurrent gastric cancer


subject: UMLS:C4528197

object_name: Bladder cancer recurrent


subject: UMLS:C4528197

object_name: Recurrent Liver Carcinoma


subject: UMLS:C4528197

object_name: Colon cancer recurrent


subject: UMLS:C4528197

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C4528197

object_name: Recurrent Skin Carcinoma


subject: UMLS:C4528197

object_name: thyroid gland carcinoma


subject: UMLS:C4528197

object_name: breast carcinoma


subject: UMLS:C4528197

object_name: colorectal carcinoma


subject: UMLS:C4528197

object_name: Melanoma recurrent


subject: UMLS:C4528197

object_name: carcinoma of esophagus


subject: UMLS:C4528197

object_name: rectal carcinoma


subject: UMLS:C4528197

object_name: rectum adenocarcinoma


subject: UMLS:C4528197

object_name: Recurrent Glioma


subject: UMLS:C4528197

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4528197

object_name: cervical carcinoma


subject: UMLS:C4528197

object_name: prostate carcinoma


subject: UMLS:C4528197

object_name: Stomach cancer


subject: UMLS:C4528197

object_name: ovarian cancer


subject: UMLS:C4528197

object_name: ovarian carcinoma


subject: UMLS:C4528197

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4528197

object_name: urinary bladder carcinoma


subject: UMLS:C4528197

object_name: renal carcinoma


subject: UMLS:C4528197

object_name: renal cell carcinoma


subject: UMLS:C4528197

object_name: liver carcinoma


subject: UMLS:C4528197

object_name: colon carcinoma


subject: UMLS:C4528197

object_name: lung carcinoma


subject: UMLS:C4528197

object_name: skin carcinoma


subject: UMLS:C4528197

object_name: melanoma


subject: UMLS:C4528197

object_name: glioma


subject: UMLS:C4528197

object_name: malignant glioma


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: plasma cell myeloma


subject: CHEBI:77562

object_name: adult lymphoma


subject: CHEBI:77562

object_name: lymphoma


subject: CHEBI:77562

object_name: pediatric lymphoma


subject: CHEBI:77562

object_name: Plasma cell myeloma recurrent


subject: CHEBI:77562

object_name: Recurrent Lymphoma


subject: CHEBI:77562

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:77562

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:77562

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:77562

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:77562

object_name: Recurrent Rectal Cancer


subject: CHEBI:77562

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:77562

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:77562

object_name: Neck Carcinoma


subject: CHEBI:77562

object_name: uterine corpus cancer


subject: CHEBI:77562

object_name: Prostate cancer recurrent


subject: CHEBI:77562

object_name: endometrial carcinoma


subject: CHEBI:77562

object_name: uterine cancer


subject: CHEBI:77562

object_name: Breast cancer recurrent


subject: CHEBI:77562

object_name: Colorectal cancer recurrent


subject: CHEBI:77562

object_name: Recurrent ovarian cancer


subject: CHEBI:77562

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:77562

object_name: Cervix carcinoma recurrent


subject: CHEBI:77562

object_name: exocrine pancreatic carcinoma


subject: CHEBI:77562

object_name: recurrent gastric cancer


subject: CHEBI:77562

object_name: Bladder cancer recurrent


subject: CHEBI:77562

object_name: Recurrent Liver Carcinoma


subject: CHEBI:77562

object_name: Colon cancer recurrent


subject: CHEBI:77562

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:77562

object_name: Recurrent Skin Carcinoma


subject: CHEBI:77562

object_name: thyroid gland carcinoma


subject: CHEBI:77562

object_name: breast carcinoma


subject: CHEBI:77562

object_name: colorectal carcinoma


subject: CHEBI:77562

object_name: Melanoma recurrent


subject: CHEBI:77562

object_name: carcinoma of esophagus


subject: CHEBI:77562

object_name: rectal carcinoma


subject: CHEBI:77562

object_name: rectum adenocarcinoma


subject: CHEBI:77562

object_name: Recurrent Glioma


subject: CHEBI:77562

object_name: suppressor of tumorigenicity 3


subject: CHEBI:77562

object_name: cervical carcinoma


subject: CHEBI:77562

object_name: prostate carcinoma


subject: CHEBI:77562

object_name: Stomach cancer


subject: CHEBI:77562

object_name: ovarian cancer


subject: CHEBI:77562

object_name: ovarian carcinoma


subject: CHEBI:77562

object_name: malignant epithelial tumor of ovary


subject: CHEBI:77562

object_name: urinary bladder carcinoma


subject: CHEBI:77562

object_name: renal carcinoma


subject: CHEBI:77562

object_name: colon carcinoma


subject: CHEBI:77562

object_name: skin carcinoma


subject: CHEBI:77562

object_name: melanoma


subject: CHEBI:77562

object_name: glioma


subject: CHEBI:77562

object_name: malignant glioma


subject: CHEBI:64310

subject_name: Crizotinib

object_name: plasma cell myeloma


subject: CHEBI:64310

object_name: adult lymphoma


subject: CHEBI:64310

object_name: lymphoma


subject: CHEBI:64310

object_name: pediatric lymphoma


subject: CHEBI:64310

object_name: Plasma cell myeloma recurrent


subject: CHEBI:64310

object_name: Recurrent Lymphoma


subject: CHEBI:64310

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:64310

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:64310

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:64310

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:64310

object_name: Recurrent Rectal Cancer


subject: CHEBI:64310

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:64310

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:64310

object_name: Neck Carcinoma


subject: CHEBI:64310

object_name: uterine corpus cancer


subject: CHEBI:64310

object_name: Prostate cancer recurrent


subject: CHEBI:64310

object_name: endometrial carcinoma


subject: CHEBI:64310

object_name: uterine cancer


subject: CHEBI:64310

object_name: Breast cancer recurrent


subject: CHEBI:64310

object_name: Colorectal cancer recurrent


subject: CHEBI:64310

object_name: Recurrent ovarian cancer


subject: CHEBI:64310

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:64310

object_name: Cervix carcinoma recurrent


subject: CHEBI:64310

object_name: exocrine pancreatic carcinoma


subject: CHEBI:64310

object_name: recurrent gastric cancer


subject: CHEBI:64310

object_name: Bladder cancer recurrent


subject: CHEBI:64310

object_name: Recurrent Liver Carcinoma


subject: CHEBI:64310

object_name: Colon cancer recurrent


subject: CHEBI:64310

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:64310

object_name: Recurrent Skin Carcinoma


subject: CHEBI:64310

object_name: thyroid gland carcinoma


subject: CHEBI:64310

object_name: breast carcinoma


subject: CHEBI:64310

object_name: colorectal carcinoma


subject: CHEBI:64310

object_name: Melanoma recurrent


subject: CHEBI:64310

object_name: carcinoma of esophagus


subject: CHEBI:64310

object_name: rectal carcinoma


subject: CHEBI:64310

object_name: rectum adenocarcinoma


subject: CHEBI:64310

object_name: Recurrent Glioma


subject: CHEBI:64310

object_name: suppressor of tumorigenicity 3


subject: CHEBI:64310

object_name: cervical carcinoma


subject: CHEBI:64310

object_name: prostate carcinoma


subject: CHEBI:64310

object_name: ovarian cancer


subject: CHEBI:64310

object_name: ovarian carcinoma


subject: CHEBI:64310

object_name: malignant epithelial tumor of ovary


subject: CHEBI:64310

object_name: urinary bladder carcinoma


subject: CHEBI:64310

object_name: renal carcinoma


subject: CHEBI:64310

object_name: colon carcinoma


subject: CHEBI:64310

object_name: skin carcinoma


subject: CHEBI:64310

object_name: melanoma


subject: CHEBI:64310

object_name: glioma


subject: CHEBI:64310

object_name: malignant glioma


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: plasma cell myeloma


subject: CHEBI:75045

object_name: adult lymphoma


subject: CHEBI:75045

object_name: lymphoma


subject: CHEBI:75045

object_name: pediatric lymphoma


subject: CHEBI:75045

object_name: Plasma cell myeloma refractory


subject: CHEBI:75045

object_name: Refractory Lymphoma


subject: CHEBI:75045

object_name: Advanced Lymphoma


subject: CHEBI:75045

object_name: Plasma cell myeloma recurrent


subject: CHEBI:75045

object_name: Recurrent Lymphoma


subject: CHEBI:75045

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:75045

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:75045

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:75045

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:75045

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:75045

object_name: Recurrent Rectal Cancer


subject: CHEBI:75045

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:75045

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:75045

object_name: Neck Carcinoma


subject: CHEBI:75045

object_name: uterine corpus cancer


subject: CHEBI:75045

object_name: Prostate cancer recurrent


subject: CHEBI:75045

object_name: endometrial carcinoma


subject: CHEBI:75045

object_name: uterine cancer


subject: CHEBI:75045

object_name: Breast cancer recurrent


subject: CHEBI:75045

object_name: Colorectal cancer recurrent


subject: CHEBI:75045

object_name: Recurrent ovarian cancer


subject: CHEBI:75045

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:75045

object_name: Cervix carcinoma recurrent


subject: CHEBI:75045

object_name: exocrine pancreatic carcinoma


subject: CHEBI:75045

object_name: recurrent gastric cancer


subject: CHEBI:75045

object_name: Bladder cancer recurrent


subject: CHEBI:75045

object_name: Recurrent Liver Carcinoma


subject: CHEBI:75045

object_name: Colon cancer recurrent


subject: CHEBI:75045

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:75045

object_name: Recurrent Skin Carcinoma


subject: CHEBI:75045

object_name: breast carcinoma


subject: CHEBI:75045

object_name: colorectal carcinoma


subject: CHEBI:75045

object_name: carcinoma of esophagus


subject: CHEBI:75045

object_name: rectal carcinoma


subject: CHEBI:75045

object_name: rectum adenocarcinoma


subject: CHEBI:75045

object_name: Recurrent Glioma


subject: CHEBI:75045

object_name: suppressor of tumorigenicity 3


subject: CHEBI:75045

object_name: cervical carcinoma


subject: CHEBI:75045

object_name: prostate carcinoma


subject: CHEBI:75045

object_name: Stomach cancer


subject: CHEBI:75045

object_name: ovarian cancer


subject: CHEBI:75045

object_name: ovarian carcinoma


subject: CHEBI:75045

object_name: malignant epithelial tumor of ovary


subject: CHEBI:75045

object_name: urinary bladder carcinoma


subject: CHEBI:75045

object_name: renal carcinoma


subject: CHEBI:75045

object_name: renal cell carcinoma


subject: CHEBI:75045

object_name: liver carcinoma


subject: CHEBI:75045

object_name: colon carcinoma


subject: CHEBI:75045

object_name: lung carcinoma


subject: CHEBI:75045

object_name: skin carcinoma


subject: CHEBI:75045

object_name: glioma


subject: CHEBI:75045

object_name: malignant glioma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Plasma cell myeloma refractory


subject: CHEBI:70839

object_name: Refractory Lymphoma


subject: CHEBI:70839

object_name: Advanced Lymphoma


subject: CHEBI:70839

object_name: Plasma cell myeloma recurrent


subject: CHEBI:70839

object_name: Recurrent Lymphoma


subject: CHEBI:70839

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:70839

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:70839

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:70839

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:70839

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:70839

object_name: Recurrent Rectal Cancer


subject: CHEBI:70839

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:70839

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:70839

object_name: Neck Carcinoma


subject: CHEBI:70839

object_name: uterine corpus cancer


subject: CHEBI:70839

object_name: endometrial carcinoma


subject: CHEBI:70839

object_name: uterine cancer


subject: CHEBI:70839

object_name: Breast cancer recurrent


subject: CHEBI:70839

object_name: Colorectal cancer recurrent


subject: CHEBI:70839

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:70839

object_name: Cervix carcinoma recurrent


subject: CHEBI:70839

object_name: recurrent gastric cancer


subject: CHEBI:70839

object_name: Bladder cancer recurrent


subject: CHEBI:70839

object_name: Recurrent Liver Carcinoma


subject: CHEBI:70839

object_name: Colon cancer recurrent


subject: CHEBI:70839

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:70839

object_name: Recurrent Skin Carcinoma


subject: CHEBI:70839

object_name: thyroid gland carcinoma


subject: CHEBI:70839

object_name: colorectal carcinoma


subject: CHEBI:70839

object_name: Melanoma recurrent


subject: CHEBI:70839

object_name: carcinoma of esophagus


subject: CHEBI:70839

object_name: rectal carcinoma


subject: CHEBI:70839

object_name: rectum adenocarcinoma


subject: CHEBI:70839

object_name: Recurrent Glioma


subject: CHEBI:70839

object_name: suppressor of tumorigenicity 3


subject: CHEBI:70839

object_name: cervical carcinoma


subject: CHEBI:70839

object_name: prostate carcinoma


subject: CHEBI:70839

object_name: Stomach cancer


subject: CHEBI:70839

object_name: malignant epithelial tumor of ovary


subject: CHEBI:70839

object_name: urinary bladder carcinoma


subject: CHEBI:70839

object_name: renal cell carcinoma


subject: CHEBI:70839

object_name: colon carcinoma


subject: CHEBI:70839

object_name: skin carcinoma


subject: CHEBI:190514

object_name: Plasma cell myeloma refractory


subject: CHEBI:190514

object_name: Refractory Lymphoma


subject: CHEBI:190514

object_name: Advanced Lymphoma


subject: CHEBI:190514

object_name: Plasma cell myeloma recurrent


subject: CHEBI:190514

object_name: Recurrent Lymphoma


subject: CHEBI:190514

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:190514

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:190514

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:190514

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:190514

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:190514

object_name: Recurrent Rectal Cancer


subject: CHEBI:190514

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:190514

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:190514

object_name: Neck Carcinoma


subject: CHEBI:190514

object_name: uterine corpus cancer


subject: CHEBI:190514

object_name: endometrial carcinoma


subject: CHEBI:190514

object_name: uterine cancer


subject: CHEBI:190514

object_name: Breast cancer recurrent


subject: CHEBI:190514

object_name: Colorectal cancer recurrent


subject: CHEBI:190514

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:190514

object_name: Cervix carcinoma recurrent


subject: CHEBI:190514

object_name: recurrent gastric cancer


subject: CHEBI:190514

object_name: Bladder cancer recurrent


subject: CHEBI:190514

object_name: Recurrent Liver Carcinoma


subject: CHEBI:190514

object_name: Colon cancer recurrent


subject: CHEBI:190514

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:190514

object_name: Recurrent Skin Carcinoma


subject: CHEBI:190514

object_name: thyroid gland carcinoma


subject: CHEBI:190514

object_name: colorectal carcinoma


subject: CHEBI:190514

object_name: Melanoma recurrent


subject: CHEBI:190514

object_name: carcinoma of esophagus


subject: CHEBI:190514

object_name: rectal carcinoma


subject: CHEBI:190514

object_name: rectum adenocarcinoma


subject: CHEBI:190514

object_name: Recurrent Glioma


subject: CHEBI:190514

object_name: suppressor of tumorigenicity 3


subject: CHEBI:190514

object_name: cervical carcinoma


subject: CHEBI:190514

object_name: prostate carcinoma


subject: CHEBI:190514

object_name: Stomach cancer


subject: CHEBI:190514

object_name: malignant epithelial tumor of ovary


subject: CHEBI:190514

object_name: urinary bladder carcinoma


subject: CHEBI:190514

object_name: renal cell carcinoma


subject: CHEBI:190514

object_name: colon carcinoma


subject: CHEBI:190514

object_name: skin carcinoma


subject: CHEBI:49375

object_name: Plasma cell myeloma refractory


subject: CHEBI:49375

object_name: Refractory Lymphoma


subject: CHEBI:49375

object_name: Advanced Lymphoma


subject: CHEBI:49375

object_name: Plasma cell myeloma recurrent


subject: CHEBI:49375

object_name: Recurrent Lymphoma


subject: CHEBI:49375

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:49375

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:49375

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:49375

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:49375

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:49375

object_name: Recurrent Rectal Cancer


subject: CHEBI:49375

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:49375

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:49375

object_name: Neck Carcinoma


subject: CHEBI:49375

object_name: uterine corpus cancer


subject: CHEBI:49375

object_name: endometrial carcinoma


subject: CHEBI:49375

object_name: uterine cancer


subject: CHEBI:49375

object_name: Breast cancer recurrent


subject: CHEBI:49375

object_name: Colorectal cancer recurrent


subject: CHEBI:49375

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:49375

object_name: Cervix carcinoma recurrent


subject: CHEBI:49375

object_name: recurrent gastric cancer


subject: CHEBI:49375

object_name: Bladder cancer recurrent


subject: CHEBI:49375

object_name: Recurrent Liver Carcinoma


subject: CHEBI:49375

object_name: Colon cancer recurrent


subject: CHEBI:49375

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:49375

object_name: Recurrent Skin Carcinoma


subject: CHEBI:49375

object_name: thyroid gland carcinoma


subject: CHEBI:49375

object_name: colorectal carcinoma


subject: CHEBI:49375

object_name: Melanoma recurrent


subject: CHEBI:49375

object_name: carcinoma of esophagus


subject: CHEBI:49375

object_name: rectal carcinoma


subject: CHEBI:49375

object_name: rectum adenocarcinoma


subject: CHEBI:49375

object_name: Recurrent Glioma


subject: CHEBI:49375

object_name: suppressor of tumorigenicity 3


subject: CHEBI:49375

object_name: cervical carcinoma


subject: CHEBI:49375

object_name: prostate carcinoma


subject: CHEBI:49375

object_name: Stomach cancer


subject: CHEBI:49375

object_name: malignant epithelial tumor of ovary


subject: CHEBI:49375

object_name: urinary bladder carcinoma


subject: CHEBI:49375

object_name: renal cell carcinoma


subject: CHEBI:49375

object_name: colon carcinoma


subject: CHEBI:49375

object_name: skin carcinoma


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: plasma cell myeloma


subject: UNII:53O87HA2QU

object_name: adult lymphoma


subject: UNII:53O87HA2QU

object_name: lymphoma


subject: UNII:53O87HA2QU

object_name: pediatric lymphoma


subject: UNII:53O87HA2QU

object_name: Plasma cell myeloma recurrent


subject: UNII:53O87HA2QU

object_name: Recurrent Lymphoma


subject: UNII:53O87HA2QU

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:53O87HA2QU

object_name: Pancreatic carcinoma recurrent


subject: UNII:53O87HA2QU

object_name: Recurrent Rectal Cancer


subject: UNII:53O87HA2QU

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:53O87HA2QU

object_name: Recurrent Thyroid Carcinoma


subject: UNII:53O87HA2QU

object_name: Neck Carcinoma


subject: UNII:53O87HA2QU

object_name: uterine corpus cancer


subject: UNII:53O87HA2QU

object_name: Prostate cancer recurrent


subject: UNII:53O87HA2QU

object_name: endometrial carcinoma


subject: UNII:53O87HA2QU

object_name: uterine cancer


subject: UNII:53O87HA2QU

object_name: Breast cancer recurrent


subject: UNII:53O87HA2QU

object_name: Colorectal cancer recurrent


subject: UNII:53O87HA2QU

object_name: Recurrent ovarian cancer


subject: UNII:53O87HA2QU

object_name: Oesophageal carcinoma recurrent


subject: UNII:53O87HA2QU

object_name: Cervix carcinoma recurrent


subject: UNII:53O87HA2QU

object_name: exocrine pancreatic carcinoma


subject: UNII:53O87HA2QU

object_name: recurrent gastric cancer


subject: UNII:53O87HA2QU

object_name: Bladder cancer recurrent


subject: UNII:53O87HA2QU

object_name: Recurrent Liver Carcinoma


subject: UNII:53O87HA2QU

object_name: Colon cancer recurrent


subject: UNII:53O87HA2QU

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:53O87HA2QU

object_name: Recurrent Skin Carcinoma


subject: UNII:53O87HA2QU

object_name: thyroid gland carcinoma


subject: UNII:53O87HA2QU

object_name: breast carcinoma


subject: UNII:53O87HA2QU

object_name: colorectal carcinoma


subject: UNII:53O87HA2QU

object_name: Melanoma recurrent


subject: UNII:53O87HA2QU

object_name: carcinoma of esophagus


subject: UNII:53O87HA2QU

object_name: rectal carcinoma


subject: UNII:53O87HA2QU

object_name: rectum adenocarcinoma


subject: UNII:53O87HA2QU

object_name: Recurrent Glioma


subject: UNII:53O87HA2QU

object_name: suppressor of tumorigenicity 3


subject: UNII:53O87HA2QU

object_name: cervical carcinoma


subject: UNII:53O87HA2QU

object_name: prostate carcinoma


subject: UNII:53O87HA2QU

object_name: malignant epithelial tumor of ovary


subject: UNII:53O87HA2QU

object_name: urinary bladder carcinoma


subject: UNII:53O87HA2QU

object_name: renal carcinoma


subject: UNII:53O87HA2QU

object_name: renal cell carcinoma


subject: UNII:53O87HA2QU

object_name: liver carcinoma


subject: UNII:53O87HA2QU

object_name: colon carcinoma


subject: UNII:53O87HA2QU

object_name: lung carcinoma


subject: UNII:53O87HA2QU

object_name: skin carcinoma


subject: UNII:53O87HA2QU

object_name: glioma


subject: UNII:53O87HA2QU

object_name: malignant glioma


subject: UMLS:C4287800

subject_name: Defactinib Hydrochloride

object_name: plasma cell myeloma


subject: UMLS:C4287800

object_name: adult lymphoma


subject: UMLS:C4287800

object_name: lymphoma


subject: UMLS:C4287800

object_name: pediatric lymphoma


subject: UMLS:C4287800

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4287800

object_name: Recurrent Lymphoma


subject: UMLS:C4287800

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C4287800

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C4287800

object_name: Recurrent Rectal Cancer


subject: UMLS:C4287800

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C4287800

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C4287800

object_name: Neck Carcinoma


subject: UMLS:C4287800

object_name: uterine corpus cancer


subject: UMLS:C4287800

object_name: Prostate cancer recurrent


subject: UMLS:C4287800

object_name: endometrial carcinoma


subject: UMLS:C4287800

object_name: uterine cancer


subject: UMLS:C4287800

object_name: Breast cancer recurrent


subject: UMLS:C4287800

object_name: Colorectal cancer recurrent


subject: UMLS:C4287800

object_name: Recurrent ovarian cancer


subject: UMLS:C4287800

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C4287800

object_name: Cervix carcinoma recurrent


subject: UMLS:C4287800

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4287800

object_name: recurrent gastric cancer


subject: UMLS:C4287800

object_name: Bladder cancer recurrent


subject: UMLS:C4287800

object_name: Recurrent Liver Carcinoma


subject: UMLS:C4287800

object_name: Colon cancer recurrent


subject: UMLS:C4287800

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C4287800

object_name: Recurrent Skin Carcinoma


subject: UMLS:C4287800

object_name: thyroid gland carcinoma


subject: UMLS:C4287800

object_name: breast carcinoma


subject: UMLS:C4287800

object_name: colorectal carcinoma


subject: UMLS:C4287800

object_name: Melanoma recurrent


subject: UMLS:C4287800

object_name: carcinoma of esophagus


subject: UMLS:C4287800

object_name: rectal carcinoma


subject: UMLS:C4287800

object_name: rectum adenocarcinoma


subject: UMLS:C4287800

object_name: Recurrent Glioma


subject: UMLS:C4287800

object_name: suppressor of tumorigenicity 3


subject: UMLS:C4287800

object_name: cervical carcinoma


subject: UMLS:C4287800

object_name: prostate carcinoma


subject: UMLS:C4287800

object_name: Stomach cancer


subject: UMLS:C4287800

object_name: ovarian cancer


subject: UMLS:C4287800

object_name: ovarian carcinoma


subject: UMLS:C4287800

object_name: malignant epithelial tumor of ovary


subject: UMLS:C4287800

object_name: urinary bladder carcinoma


subject: UMLS:C4287800

object_name: renal carcinoma


subject: UMLS:C4287800

object_name: renal cell carcinoma


subject: UMLS:C4287800

object_name: liver carcinoma


subject: UMLS:C4287800

object_name: colon carcinoma


subject: UMLS:C4287800

object_name: lung carcinoma


subject: UMLS:C4287800

object_name: skin carcinoma


subject: UMLS:C4287800

object_name: melanoma


subject: UMLS:C4287800

object_name: glioma


subject: UMLS:C4287800

object_name: malignant glioma


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: plasma cell myeloma


subject: CHEBI:232556

object_name: adult lymphoma


subject: CHEBI:232556

object_name: lymphoma


subject: CHEBI:232556

object_name: pediatric lymphoma


subject: CHEBI:232556

object_name: Plasma cell myeloma refractory


subject: CHEBI:232556

object_name: Refractory Lymphoma


subject: CHEBI:232556

object_name: Advanced Lymphoma


subject: CHEBI:232556

object_name: Plasma cell myeloma recurrent


subject: CHEBI:232556

object_name: Recurrent Lymphoma


subject: CHEBI:232556

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:232556

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:232556

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:232556

object_name: Recurrent Rectal Cancer


subject: CHEBI:232556

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:232556

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:232556

object_name: Neck Carcinoma


subject: CHEBI:232556

object_name: uterine corpus cancer


subject: CHEBI:232556

object_name: Prostate cancer recurrent


subject: CHEBI:232556

object_name: endometrial carcinoma


subject: CHEBI:232556

object_name: uterine cancer


subject: CHEBI:232556

object_name: Breast cancer recurrent


subject: CHEBI:232556

object_name: Colorectal cancer recurrent


subject: CHEBI:232556

object_name: Recurrent ovarian cancer


subject: CHEBI:232556

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:232556

object_name: Cervix carcinoma recurrent


subject: CHEBI:232556

object_name: exocrine pancreatic carcinoma


subject: CHEBI:232556

object_name: recurrent gastric cancer


subject: CHEBI:232556

object_name: Recurrent Liver Carcinoma


subject: CHEBI:232556

object_name: Colon cancer recurrent


subject: CHEBI:232556

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:232556

object_name: Recurrent Skin Carcinoma


subject: CHEBI:232556

object_name: thyroid gland carcinoma


subject: CHEBI:232556

object_name: breast carcinoma


subject: CHEBI:232556

object_name: colorectal carcinoma


subject: CHEBI:232556

object_name: Melanoma recurrent


subject: CHEBI:232556

object_name: carcinoma of esophagus


subject: CHEBI:232556

object_name: rectal carcinoma


subject: CHEBI:232556

object_name: rectum adenocarcinoma


subject: CHEBI:232556

object_name: Recurrent Glioma


subject: CHEBI:232556

object_name: suppressor of tumorigenicity 3


subject: CHEBI:232556

object_name: cervical carcinoma


subject: CHEBI:232556

object_name: prostate carcinoma


subject: CHEBI:232556

object_name: Stomach cancer


subject: CHEBI:232556

object_name: malignant epithelial tumor of ovary


subject: CHEBI:232556

object_name: renal carcinoma


subject: CHEBI:232556

object_name: renal cell carcinoma


subject: CHEBI:232556

object_name: liver carcinoma


subject: CHEBI:232556

object_name: colon carcinoma


subject: CHEBI:232556

object_name: lung carcinoma


subject: CHEBI:232556

object_name: skin carcinoma


subject: CHEBI:232556

object_name: melanoma


subject: CHEBI:232556

object_name: glioma


subject: CHEBI:232556

object_name: malignant glioma


subject: CHEBI:63453

object_name: plasma cell myeloma


subject: CHEBI:63453

object_name: adult lymphoma


subject: CHEBI:63453

object_name: lymphoma


subject: CHEBI:63453

object_name: pediatric lymphoma


subject: CHEBI:63453

object_name: Plasma cell myeloma refractory


subject: CHEBI:63453

object_name: Refractory Lymphoma


subject: CHEBI:63453

object_name: Advanced Lymphoma


subject: CHEBI:63453

object_name: Plasma cell myeloma recurrent


subject: CHEBI:63453

object_name: Recurrent Lymphoma


subject: CHEBI:63453

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:63453

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:63453

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:63453

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:63453

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:63453

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:63453

object_name: Recurrent Rectal Cancer


subject: CHEBI:63453

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:63453

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:63453

object_name: Neck Carcinoma


subject: CHEBI:63453

object_name: uterine corpus cancer


subject: CHEBI:63453

object_name: Prostate cancer recurrent


subject: CHEBI:63453

object_name: endometrial carcinoma


subject: CHEBI:63453

object_name: uterine cancer


subject: CHEBI:63453

object_name: Breast cancer recurrent


subject: CHEBI:63453

object_name: Colorectal cancer recurrent


subject: CHEBI:63453

object_name: Recurrent ovarian cancer


subject: CHEBI:63453

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:63453

object_name: Cervix carcinoma recurrent


subject: CHEBI:63453

object_name: exocrine pancreatic carcinoma


subject: CHEBI:63453

object_name: recurrent gastric cancer


subject: CHEBI:63453

object_name: Bladder cancer recurrent


subject: CHEBI:63453

object_name: Recurrent Liver Carcinoma


subject: CHEBI:63453

object_name: Colon cancer recurrent


subject: CHEBI:63453

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:63453

object_name: Recurrent Skin Carcinoma


subject: CHEBI:63453

object_name: thyroid gland carcinoma


subject: CHEBI:63453

object_name: breast carcinoma


subject: CHEBI:63453

object_name: colorectal carcinoma


subject: CHEBI:63453

object_name: Melanoma recurrent


subject: CHEBI:63453

object_name: carcinoma of esophagus


subject: CHEBI:63453

object_name: rectal carcinoma


subject: CHEBI:63453

object_name: rectum adenocarcinoma


subject: CHEBI:63453

object_name: Recurrent Glioma


subject: CHEBI:63453

object_name: suppressor of tumorigenicity 3


subject: CHEBI:63453

object_name: cervical carcinoma


subject: CHEBI:63453

object_name: prostate carcinoma


subject: CHEBI:63453

object_name: Stomach cancer


subject: CHEBI:63453

object_name: ovarian cancer


subject: CHEBI:63453

object_name: ovarian carcinoma


subject: CHEBI:63453

object_name: malignant epithelial tumor of ovary


subject: CHEBI:63453

object_name: urinary bladder carcinoma


subject: CHEBI:63453

object_name: renal carcinoma


subject: CHEBI:63453

object_name: renal cell carcinoma


subject: CHEBI:63453

object_name: liver carcinoma


subject: CHEBI:63453

object_name: colon carcinoma


subject: CHEBI:63453

object_name: lung carcinoma


subject: CHEBI:63453

object_name: skin carcinoma


subject: CHEBI:63453

object_name: melanoma


subject: CHEBI:63453

object_name: glioma


subject: CHEBI:63453

object_name: malignant glioma


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: plasma cell myeloma


subject: CHEBI:95089

object_name: adult lymphoma


subject: CHEBI:95089

object_name: lymphoma


subject: CHEBI:95089

object_name: pediatric lymphoma


subject: CHEBI:95089

object_name: Plasma cell myeloma refractory


subject: CHEBI:95089

object_name: Refractory Lymphoma


subject: CHEBI:95089

object_name: Advanced Lymphoma


subject: CHEBI:95089

object_name: Plasma cell myeloma recurrent


subject: CHEBI:95089

object_name: Recurrent Lymphoma


subject: CHEBI:95089

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:95089

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:95089

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:95089

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:95089

object_name: Recurrent Rectal Cancer


subject: CHEBI:95089

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:95089

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:95089

object_name: Neck Carcinoma


subject: CHEBI:95089

object_name: uterine corpus cancer


subject: CHEBI:95089

object_name: Prostate cancer recurrent


subject: CHEBI:95089

object_name: endometrial carcinoma


subject: CHEBI:95089

object_name: uterine cancer


subject: CHEBI:95089

object_name: Breast cancer recurrent


subject: CHEBI:95089

object_name: Colorectal cancer recurrent


subject: CHEBI:95089

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:95089

object_name: Cervix carcinoma recurrent


subject: CHEBI:95089

object_name: exocrine pancreatic carcinoma


subject: CHEBI:95089

object_name: recurrent gastric cancer


subject: CHEBI:95089

object_name: Bladder cancer recurrent


subject: CHEBI:95089

object_name: Recurrent Liver Carcinoma


subject: CHEBI:95089

object_name: Colon cancer recurrent


subject: CHEBI:95089

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:95089

object_name: Recurrent Skin Carcinoma


subject: CHEBI:95089

object_name: thyroid gland carcinoma


subject: CHEBI:95089

object_name: colorectal carcinoma


subject: CHEBI:95089

object_name: Melanoma recurrent


subject: CHEBI:95089

object_name: carcinoma of esophagus


subject: CHEBI:95089

object_name: rectal carcinoma


subject: CHEBI:95089

object_name: rectum adenocarcinoma


subject: CHEBI:95089

object_name: Recurrent Glioma


subject: CHEBI:95089

object_name: suppressor of tumorigenicity 3


subject: CHEBI:95089

object_name: cervical carcinoma


subject: CHEBI:95089

object_name: Stomach cancer


subject: CHEBI:95089

object_name: ovarian cancer


subject: CHEBI:95089

object_name: ovarian carcinoma


subject: CHEBI:95089

object_name: malignant epithelial tumor of ovary


subject: CHEBI:95089

object_name: urinary bladder carcinoma


subject: CHEBI:95089

object_name: renal carcinoma


subject: CHEBI:95089

object_name: renal cell carcinoma


subject: CHEBI:95089

object_name: liver carcinoma


subject: CHEBI:95089

object_name: colon carcinoma


subject: CHEBI:95089

object_name: lung carcinoma


subject: CHEBI:95089

object_name: skin carcinoma


subject: CHEBI:95089

object_name: melanoma


subject: CHEBI:95089

object_name: glioma


subject: CHEBI:95089

object_name: malignant glioma


subject: UNII:PF9462I9HX

subject_name: Larotrectinib

object_name: adult lymphoma


subject: UNII:PF9462I9HX

object_name: lymphoma


subject: UNII:PF9462I9HX

object_name: pediatric lymphoma


subject: UNII:PF9462I9HX

object_name: Plasma cell myeloma refractory


subject: UNII:PF9462I9HX

object_name: Refractory Lymphoma


subject: UNII:PF9462I9HX

object_name: Advanced Lymphoma


subject: UNII:PF9462I9HX

object_name: Plasma cell myeloma recurrent


subject: UNII:PF9462I9HX

object_name: Recurrent Lymphoma


subject: UNII:PF9462I9HX

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:PF9462I9HX

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:PF9462I9HX

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:PF9462I9HX

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:PF9462I9HX

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:PF9462I9HX

object_name: Pancreatic carcinoma recurrent


subject: UNII:PF9462I9HX

object_name: Recurrent Rectal Cancer


subject: UNII:PF9462I9HX

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:PF9462I9HX

object_name: Recurrent Thyroid Carcinoma


subject: UNII:PF9462I9HX

object_name: Neck Carcinoma


subject: UNII:PF9462I9HX

object_name: uterine corpus cancer


subject: UNII:PF9462I9HX

object_name: Prostate cancer recurrent


subject: UNII:PF9462I9HX

object_name: endometrial carcinoma


subject: UNII:PF9462I9HX

object_name: uterine cancer


subject: UNII:PF9462I9HX

object_name: Breast cancer recurrent


subject: UNII:PF9462I9HX

object_name: Colorectal cancer recurrent


subject: UNII:PF9462I9HX

object_name: Recurrent ovarian cancer


subject: UNII:PF9462I9HX

object_name: Oesophageal carcinoma recurrent


subject: UNII:PF9462I9HX

object_name: Cervix carcinoma recurrent


subject: UNII:PF9462I9HX

object_name: exocrine pancreatic carcinoma


subject: UNII:PF9462I9HX

object_name: recurrent gastric cancer


subject: UNII:PF9462I9HX

object_name: Bladder cancer recurrent


subject: UNII:PF9462I9HX

object_name: Recurrent Liver Carcinoma


subject: UNII:PF9462I9HX

object_name: Colon cancer recurrent


subject: UNII:PF9462I9HX

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:PF9462I9HX

object_name: Recurrent Skin Carcinoma


subject: UNII:PF9462I9HX

object_name: thyroid gland carcinoma


subject: UNII:PF9462I9HX

object_name: breast carcinoma


subject: UNII:PF9462I9HX

object_name: colorectal carcinoma


subject: UNII:PF9462I9HX

object_name: Melanoma recurrent


subject: UNII:PF9462I9HX

object_name: carcinoma of esophagus


subject: UNII:PF9462I9HX

object_name: rectal carcinoma


subject: UNII:PF9462I9HX

object_name: rectum adenocarcinoma


subject: UNII:PF9462I9HX

object_name: Recurrent Glioma


subject: UNII:PF9462I9HX

object_name: suppressor of tumorigenicity 3


subject: UNII:PF9462I9HX

object_name: cervical carcinoma


subject: UNII:PF9462I9HX

object_name: prostate carcinoma


subject: UNII:PF9462I9HX

object_name: Stomach cancer


subject: UNII:PF9462I9HX

object_name: ovarian cancer


subject: UNII:PF9462I9HX

object_name: ovarian carcinoma


subject: UNII:PF9462I9HX

object_name: malignant epithelial tumor of ovary


subject: UNII:PF9462I9HX

object_name: urinary bladder carcinoma


subject: UNII:PF9462I9HX

object_name: renal carcinoma


subject: UNII:PF9462I9HX

object_name: renal cell carcinoma


subject: UNII:PF9462I9HX

object_name: liver carcinoma


subject: UNII:PF9462I9HX

object_name: colon carcinoma


subject: UNII:PF9462I9HX

object_name: lung carcinoma


subject: UNII:PF9462I9HX

object_name: skin carcinoma


subject: UNII:PF9462I9HX

object_name: melanoma


subject: UNII:PF9462I9HX

object_name: glioma


subject: UNII:RDF76R62ID

subject_name: LAROTRECTINIB SULFATE

object_name: plasma cell myeloma


subject: UNII:RDF76R62ID

object_name: adult lymphoma


subject: UNII:RDF76R62ID

object_name: lymphoma


subject: UNII:RDF76R62ID

object_name: pediatric lymphoma


subject: UNII:RDF76R62ID

object_name: Plasma cell myeloma refractory


subject: UNII:RDF76R62ID

object_name: Refractory Lymphoma


subject: UNII:RDF76R62ID

object_name: Advanced Lymphoma


subject: UNII:RDF76R62ID

object_name: Plasma cell myeloma recurrent


subject: UNII:RDF76R62ID

object_name: Recurrent Lymphoma


subject: UNII:RDF76R62ID

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:RDF76R62ID

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:RDF76R62ID

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:RDF76R62ID

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:RDF76R62ID

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:RDF76R62ID

object_name: Pancreatic carcinoma recurrent


subject: UNII:RDF76R62ID

object_name: Recurrent Rectal Cancer


subject: UNII:RDF76R62ID

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:RDF76R62ID

object_name: Recurrent Thyroid Carcinoma


subject: UNII:RDF76R62ID

object_name: Neck Carcinoma


subject: UNII:RDF76R62ID

object_name: uterine corpus cancer


subject: UNII:RDF76R62ID

object_name: Prostate cancer recurrent


subject: UNII:RDF76R62ID

object_name: endometrial carcinoma


subject: UNII:RDF76R62ID

object_name: uterine cancer


subject: UNII:RDF76R62ID

object_name: Breast cancer recurrent


subject: UNII:RDF76R62ID

object_name: Colorectal cancer recurrent


subject: UNII:RDF76R62ID

object_name: Recurrent ovarian cancer


subject: UNII:RDF76R62ID

object_name: Oesophageal carcinoma recurrent


subject: UNII:RDF76R62ID

object_name: Cervix carcinoma recurrent


subject: UNII:RDF76R62ID

object_name: exocrine pancreatic carcinoma


subject: UNII:RDF76R62ID

object_name: recurrent gastric cancer


subject: UNII:RDF76R62ID

object_name: Bladder cancer recurrent


subject: UNII:RDF76R62ID

object_name: Recurrent Liver Carcinoma


subject: UNII:RDF76R62ID

object_name: Colon cancer recurrent


subject: UNII:RDF76R62ID

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:RDF76R62ID

object_name: Recurrent Skin Carcinoma


subject: UNII:RDF76R62ID

object_name: thyroid gland carcinoma


subject: UNII:RDF76R62ID

object_name: breast carcinoma


subject: UNII:RDF76R62ID

object_name: colorectal carcinoma


subject: UNII:RDF76R62ID

object_name: Melanoma recurrent


subject: UNII:RDF76R62ID

object_name: carcinoma of esophagus


subject: UNII:RDF76R62ID

object_name: rectal carcinoma


subject: UNII:RDF76R62ID

object_name: rectum adenocarcinoma


subject: UNII:RDF76R62ID

object_name: Recurrent Glioma


subject: UNII:RDF76R62ID

object_name: suppressor of tumorigenicity 3


subject: UNII:RDF76R62ID

object_name: cervical carcinoma


subject: UNII:RDF76R62ID

object_name: prostate carcinoma


subject: UNII:RDF76R62ID

object_name: Stomach cancer


subject: UNII:RDF76R62ID

object_name: ovarian cancer


subject: UNII:RDF76R62ID

object_name: ovarian carcinoma


subject: UNII:RDF76R62ID

object_name: malignant epithelial tumor of ovary


subject: UNII:RDF76R62ID

object_name: urinary bladder carcinoma


subject: UNII:RDF76R62ID

object_name: renal carcinoma


subject: UNII:RDF76R62ID

object_name: renal cell carcinoma


subject: UNII:RDF76R62ID

object_name: liver carcinoma


subject: UNII:RDF76R62ID

object_name: colon carcinoma


subject: UNII:RDF76R62ID

object_name: lung carcinoma


subject: UNII:RDF76R62ID

object_name: skin carcinoma


subject: UNII:RDF76R62ID

object_name: melanoma


subject: UNII:RDF76R62ID

object_name: glioma


subject: UNII:RDF76R62ID

object_name: malignant glioma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:231614

object_name: Recurrent Rectal Cancer


subject: CHEBI:231614

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:231614

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:231614

object_name: uterine corpus cancer


subject: CHEBI:231614

object_name: Breast cancer recurrent


subject: CHEBI:231614

object_name: Colorectal cancer recurrent


subject: CHEBI:231614

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:231614

object_name: recurrent gastric cancer


subject: CHEBI:231614

object_name: Bladder cancer recurrent


subject: CHEBI:231614

object_name: Recurrent Liver Carcinoma


subject: CHEBI:231614

object_name: Colon cancer recurrent


subject: CHEBI:231614

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:231614

object_name: Recurrent Skin Carcinoma


subject: CHEBI:231614

object_name: Recurrent Glioma


subject: CHEBI:231614

object_name: suppressor of tumorigenicity 3


subject: CHEBI:231614

object_name: skin carcinoma


subject: UMLS:C2346820

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C2346820

object_name: Recurrent Rectal Cancer


subject: UMLS:C2346820

object_name: Recurrent Head and Neck Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C2346820

object_name: uterine corpus cancer


subject: UMLS:C2346820

object_name: Breast cancer recurrent


subject: UMLS:C2346820

object_name: Colorectal cancer recurrent


subject: UMLS:C2346820

object_name: Oesophageal carcinoma recurrent


subject: UMLS:C2346820

object_name: recurrent gastric cancer


subject: UMLS:C2346820

object_name: Bladder cancer recurrent


subject: UMLS:C2346820

object_name: Recurrent Liver Carcinoma


subject: UMLS:C2346820

object_name: Colon cancer recurrent


subject: UMLS:C2346820

object_name: Recurrent Unspecified Lung Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Skin Carcinoma


subject: UMLS:C2346820

object_name: Recurrent Glioma


subject: UMLS:C2346820

object_name: suppressor of tumorigenicity 3


subject: UMLS:C2346820

object_name: skin carcinoma


subject: CHEBI:90943

subject_name: Osimertinib

object_name: plasma cell myeloma


subject: CHEBI:90943

object_name: adult lymphoma


subject: CHEBI:90943

object_name: lymphoma


subject: CHEBI:90943

object_name: pediatric lymphoma


subject: CHEBI:90943

object_name: Plasma cell myeloma refractory


subject: CHEBI:90943

object_name: Refractory Lymphoma


subject: CHEBI:90943

object_name: Advanced Lymphoma


subject: CHEBI:90943

object_name: Plasma cell myeloma recurrent


subject: CHEBI:90943

object_name: Recurrent Lymphoma


subject: CHEBI:90943

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:90943

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:90943

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:90943

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:90943

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:90943

object_name: Recurrent Rectal Cancer


subject: CHEBI:90943

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:90943

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:90943

object_name: Neck Carcinoma


subject: CHEBI:90943

object_name: uterine corpus cancer


subject: CHEBI:90943

object_name: Prostate cancer recurrent


subject: CHEBI:90943

object_name: endometrial carcinoma


subject: CHEBI:90943

object_name: uterine cancer


subject: CHEBI:90943

object_name: Breast cancer recurrent


subject: CHEBI:90943

object_name: Colorectal cancer recurrent


subject: CHEBI:90943

object_name: Recurrent ovarian cancer


subject: CHEBI:90943

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:90943

object_name: Cervix carcinoma recurrent


subject: CHEBI:90943

object_name: exocrine pancreatic carcinoma


subject: CHEBI:90943

object_name: recurrent gastric cancer


subject: CHEBI:90943

object_name: Bladder cancer recurrent


subject: CHEBI:90943

object_name: Recurrent Liver Carcinoma


subject: CHEBI:90943

object_name: Colon cancer recurrent


subject: CHEBI:90943

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:90943

object_name: Recurrent Skin Carcinoma


subject: CHEBI:90943

object_name: thyroid gland carcinoma


subject: CHEBI:90943

object_name: breast carcinoma


subject: CHEBI:90943

object_name: colorectal carcinoma


subject: CHEBI:90943

object_name: Melanoma recurrent


subject: CHEBI:90943

object_name: carcinoma of esophagus


subject: CHEBI:90943

object_name: rectal carcinoma


subject: CHEBI:90943

object_name: rectum adenocarcinoma


subject: CHEBI:90943

object_name: Recurrent Glioma


subject: CHEBI:90943

object_name: suppressor of tumorigenicity 3


subject: CHEBI:90943

object_name: cervical carcinoma


subject: CHEBI:90943

object_name: prostate carcinoma


subject: CHEBI:90943

object_name: Stomach cancer


subject: CHEBI:90943

object_name: ovarian cancer


subject: CHEBI:90943

object_name: ovarian carcinoma


subject: CHEBI:90943

object_name: malignant epithelial tumor of ovary


subject: CHEBI:90943

object_name: urinary bladder carcinoma


subject: CHEBI:90943

object_name: renal carcinoma


subject: CHEBI:90943

object_name: renal cell carcinoma


subject: CHEBI:90943

object_name: liver carcinoma


subject: CHEBI:90943

object_name: colon carcinoma


subject: CHEBI:90943

object_name: skin carcinoma


subject: CHEBI:90943

object_name: melanoma


subject: CHEBI:90943

object_name: glioma


subject: CHEBI:90943

object_name: malignant glioma


subject: UNII:DW94IAT0LS

object_name: plasma cell myeloma


subject: UNII:DW94IAT0LS

object_name: adult lymphoma


subject: UNII:DW94IAT0LS

object_name: lymphoma


subject: UNII:DW94IAT0LS

object_name: pediatric lymphoma


subject: UNII:DW94IAT0LS

object_name: Plasma cell myeloma refractory


subject: UNII:DW94IAT0LS

object_name: Refractory Lymphoma


subject: UNII:DW94IAT0LS

object_name: Advanced Lymphoma


subject: UNII:DW94IAT0LS

object_name: Plasma cell myeloma recurrent


subject: UNII:DW94IAT0LS

object_name: Recurrent Lymphoma


subject: UNII:DW94IAT0LS

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:DW94IAT0LS

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:DW94IAT0LS

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:DW94IAT0LS

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:DW94IAT0LS

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:DW94IAT0LS

object_name: Pancreatic carcinoma recurrent


subject: UNII:DW94IAT0LS

object_name: Recurrent Rectal Cancer


subject: UNII:DW94IAT0LS

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:DW94IAT0LS

object_name: Recurrent Thyroid Carcinoma


subject: UNII:DW94IAT0LS

object_name: Neck Carcinoma


subject: UNII:DW94IAT0LS

object_name: uterine corpus cancer


subject: UNII:DW94IAT0LS

object_name: Prostate cancer recurrent


subject: UNII:DW94IAT0LS

object_name: endometrial carcinoma


subject: UNII:DW94IAT0LS

object_name: uterine cancer


subject: UNII:DW94IAT0LS

object_name: Breast cancer recurrent


subject: UNII:DW94IAT0LS

object_name: Colorectal cancer recurrent


subject: UNII:DW94IAT0LS

object_name: Recurrent ovarian cancer


subject: UNII:DW94IAT0LS

object_name: Oesophageal carcinoma recurrent


subject: UNII:DW94IAT0LS

object_name: Cervix carcinoma recurrent


subject: UNII:DW94IAT0LS

object_name: exocrine pancreatic carcinoma


subject: UNII:DW94IAT0LS

object_name: recurrent gastric cancer


subject: UNII:DW94IAT0LS

object_name: Bladder cancer recurrent


subject: UNII:DW94IAT0LS

object_name: Recurrent Liver Carcinoma


subject: UNII:DW94IAT0LS

object_name: Colon cancer recurrent


subject: UNII:DW94IAT0LS

object_name: Recurrent Unspecified Lung Carcinoma


subject: UNII:DW94IAT0LS

object_name: Recurrent Skin Carcinoma


subject: UNII:DW94IAT0LS

object_name: thyroid gland carcinoma


subject: UNII:DW94IAT0LS

object_name: breast carcinoma


subject: UNII:DW94IAT0LS

object_name: colorectal carcinoma


subject: UNII:DW94IAT0LS

object_name: Melanoma recurrent


subject: UNII:DW94IAT0LS

object_name: carcinoma of esophagus


subject: UNII:DW94IAT0LS

object_name: rectal carcinoma


subject: UNII:DW94IAT0LS

object_name: rectum adenocarcinoma


subject: UNII:DW94IAT0LS

object_name: Recurrent Glioma


subject: UNII:DW94IAT0LS

object_name: suppressor of tumorigenicity 3


subject: UNII:DW94IAT0LS

object_name: cervical carcinoma


subject: UNII:DW94IAT0LS

object_name: prostate carcinoma


subject: UNII:DW94IAT0LS

object_name: Stomach cancer


subject: UNII:DW94IAT0LS

object_name: ovarian cancer


subject: UNII:DW94IAT0LS

object_name: ovarian carcinoma


subject: UNII:DW94IAT0LS

object_name: malignant epithelial tumor of ovary


subject: UNII:DW94IAT0LS

object_name: urinary bladder carcinoma


subject: UNII:DW94IAT0LS

object_name: renal carcinoma


subject: UNII:DW94IAT0LS

object_name: renal cell carcinoma


subject: UNII:DW94IAT0LS

object_name: liver carcinoma


subject: UNII:DW94IAT0LS

object_name: colon carcinoma


subject: UNII:DW94IAT0LS

object_name: lung carcinoma


subject: UNII:DW94IAT0LS

object_name: skin carcinoma


subject: UNII:DW94IAT0LS

object_name: melanoma


subject: UNII:DW94IAT0LS

object_name: glioma


subject: UNII:DW94IAT0LS

object_name: malignant glioma


subject: CHEBI:85993

subject_name: Palbociclib

object_name: adult lymphoma


subject: CHEBI:85993

object_name: lymphoma


subject: CHEBI:85993

object_name: pediatric lymphoma


subject: CHEBI:85993

object_name: Plasma cell myeloma refractory


subject: CHEBI:85993

object_name: Plasma cell myeloma recurrent


subject: CHEBI:85993

object_name: Recurrent Lymphoma


subject: CHEBI:85993

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:85993

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:85993

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:85993

object_name: Recurrent Rectal Cancer


subject: CHEBI:85993

object_name: Recurrent Head and Neck Carcinoma


subject: CHEBI:85993

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:85993

object_name: Neck Carcinoma


subject: CHEBI:85993

object_name: uterine corpus cancer


subject: CHEBI:85993

object_name: Prostate cancer recurrent


subject: CHEBI:85993

object_name: endometrial carcinoma


subject: CHEBI:85993

object_name: uterine cancer


subject: CHEBI:85993

object_name: Colorectal cancer recurrent


subject: CHEBI:85993

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:85993

object_name: Cervix carcinoma recurrent


subject: CHEBI:85993

object_name: recurrent gastric cancer


subject: CHEBI:85993

object_name: Bladder cancer recurrent


subject: CHEBI:85993

object_name: Recurrent Liver Carcinoma


subject: CHEBI:85993

object_name: Colon cancer recurrent


subject: CHEBI:85993

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:85993

object_name: Recurrent Skin Carcinoma


subject: CHEBI:85993

object_name: thyroid gland carcinoma


subject: CHEBI:85993

object_name: Melanoma recurrent


subject: CHEBI:85993

object_name: carcinoma of esophagus


subject: CHEBI:85993

object_name: rectal carcinoma


subject: CHEBI:85993

object_name: rectum adenocarcinoma


subject: CHEBI:85993

object_name: suppressor of tumorigenicity 3


subject: CHEBI:85993

object_name: cervical carcinoma


subject: CHEBI:85993

object_name: prostate carcinoma


subject: CHEBI:85993

object_name: Stomach cancer


subject: CHEBI:85993

object_name: malignant epithelial tumor of ovary


subject: CHEBI:85993

object_name: urinary bladder carcinoma


subject: CHEBI:85993

object_name: colon carcinoma


subject: CHEBI:85993

object_name: lung carcinoma


subject: CHEBI:85993

object_name: skin carcinoma


subject: CHEBI:85993

object_name: glioma


subject: CHEBI:85993

object_name: malignant glioma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: adult lymphoma


subject: UNII:K16AIQ8CTM

object_name: lymphoma


subject: UNII:K16AIQ8CTM

object_name: pediatric lymphoma


subject: UNII:K16AIQ8CTM

object_name: Plasma cell myeloma refractory


subject: UNII:K16AIQ8CTM

object_name: Refractory Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Advanced Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Plasma cell myeloma recurrent


subject: UNII:K16AIQ8CTM

object_name: Recurrent Lymphoma


subject: UNII:K16AIQ8CTM

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:K16AIQ8CTM

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:K16AIQ8CTM

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:K16AIQ8CTM

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:K16AIQ8CTM

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:K16AIQ8CTM

object_name: Pancreatic carcinoma recurrent


subject: UNII:K16AIQ8CTM

object_name: Recurrent Head and Neck Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Recurrent Thyroid Carcinoma


subject: UNII:K16AIQ8CTM

object_name: Neck Carcinoma


subject: UNII:K16AIQ8CTM

object_name: uterine corpus cancer


subject: UNII:K16AIQ8CTM

object_name: Prostate cancer recurrent


subject: UNII:K16AIQ8CTM

object_name: endometrial carcinoma


subject: UNII:K16AIQ8CTM

object_name: uterine cancer


subject: UNII:K16AIQ8CTM

object_name: Colorectal cancer recurrent


subject: UNII:K16AIQ8CTM

object_name: Recurrent ovarian cancer